| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $130.1M | +68.1% |
| Cost of Revenue | $13.4M | +43.7% |
| R&D Expense | $238.0M | +76.3% |
| SG&A Expense | $144.3M | +22.8% |
| Operating Income | -$265.5M | -44.0% |
| Pre-tax Income | -$260.3M | -41.4% |
| Income Tax | $346K | -38.7% |
| Net Income | -$260.6M | -41.1% |
| EPS (Basic) | -$4.34 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.1M | +48.4% |
| Short-term Investments | $231.4M | +7.3% |
| Accounts Receivable | $18.5M | +24.5% |
| Inventory | $18.7M | +117.3% |
| Current Assets | $374.2M | +21.4% |
| Total Assets | $392.3M | +17.9% |
| Current Liabilities | $115.5M | +109.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$113.9M | +16.4% |
| Capital Expenditures | $47K | +0.0% |
| Investing Cash Flow | -$48.2M | -750.4% |
| Financing Cash Flow | $191.2M | +157.2% |
| Free Cash Flow | -$113.9M | +16.4% |
| -35.6% |
| EPS (Diluted) | -$4.34 | -35.6% |
| Long-term Debt |
| $108.3M |
| +2.0% |
| Total Liabilities | $227.7M | +39.7% |
| Stockholders' Equity | $21.7M | -87.2% |